If you live in Washington DC, you can treat symptoms of Major Depressive Disorder with comorbid anxiety by using NeuroStar TMS therapy. At Genesis TMS and Wellness, we focus on a predictable, non-invasive TMS process that targets your mental health condition with magnetic pulses while you remain awake and able to resume your day.

How NeuroStar TMS Addresses Depression With Comorbid Anxiety

Anxious depression blends persistent low mood with heightened worry, restlessness, and difficulty concentrating. NeuroStar TMS uses a coil to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region often underactive in depression. Over a structured 7-week course, repeated stimulation helps strengthen neural pathways linked to mood regulation while you continue daily routines. 

Real-world data show that 83% of patients experienced improvement with NeuroStar (Sackeim HA, et al. (2020). J Affect Disord, 277:65–74). Because stimulation is localized, you avoid the systemic exposure associated with many medications. For adults 22 and older in Washington DC, this targeted approach to treating anxious depression can complement ongoing therapy and coping strategies.

What Treatment Feels Like Day-to-Day

A typical weekday session lasts about 19 minutes. After a brief motor-threshold check to calibrate intensity, you will feel rhythmic tapping on the scalp as magnetic pulses reach a few centimeters into the cortex. You can read, listen to music, or rest while the machine is working. 

Some people notice temporary scalp tenderness or a mild headache that eases the same day. Many return to work or errands immediately after the appointment, making for an easily managed schedule. This session flow remains consistent across the course so you know exactly what to expect.

Timeline, Results, and Durability of TMS Therapy

We track mood scales across treatment to monitor progress and guide any comfort adjustments while staying within FDA-cleared parameters. Published research shows results can last up to twelve months before reassessment (Dunner DL, et al. (2014). J Clin Psychiatry, 75(12):1394-1401). 

Across the United States, NeuroStar reports over 7.9 million treatments delivered to more than 216,000 patients, reflecting broad clinical use. Side effects are considered moderate risk and typically transient, with cognitive function generally preserved in studied populations. Our goal is to keep the process transparent so you can plan around work, family, and obligations.

Safety, Screening, and Coverage Details for TMS Therapy

Your safety begins with screening for seizure history, recent head injury, and ferromagnetic implants near the head. In addition to anxious depression, NeuroStar TMS is FDA-cleared for Major Depressive Disorder (MDD) and as an adjunct for obsessive-compulsive disorder (OCD) in adults. 

We verify benefits before starting and submit required documentation throughout the 7 weeks; please note that we do not accept Cigna for NeuroStar services. We follow manufacturer guidance and FDA-cleared settings for every session. 

DC Patients Can Take the Next Step With NeuroStar TMS Therapy for Anxious Depression

If you suffer from anxious depression in Washington DC and need to find relief, NeuroStar TMS therapy should be at the top of mind. We will walk you through eligibility, insurance verification, and the 7-week plan so you can move ahead with confidence. Contact us to schedule your consultation and learn how you may be able to address your anxious depression.